Rockwell Medical Technologies (RMTI) Posts Narrwer than Expected Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $7.99 -1.24%
Revenue Growth %: +14.9%
Financial Fact:
Research and Product Development: 1.26M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: +14.9%
Financial Fact:
Research and Product Development: 1.26M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Rockwell Medical Technologies (NASDAQ: RMTI) reported Q1 EPS of ($0.54), $0.03 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $12 million versus the consensus estimate of $11.52 million.
For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.
For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Red Rock Resorts (RRR) PT Lowered to $60 at StoneX
- RxSight Inc. (RXST) PT Lowered to $5 at Stifel
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
